Funded Startups in Fort Lauderdale
Among the 47 rows shown, the largest disclosed round is Growve’s $225M debt financing on 2022-01-05, which dwarfs the next-largest disclosed amounts (examp…
Among the 47 rows shown, the largest disclosed round is Growve’s $225M debt financing on 2022-01-05, which dwarfs the next-largest disclosed amounts (examples include EnergyX at $75M on 2024-10-04 and Syncromune at $100M on 2024-12-20). At the low end, several rounds disclose only $100K (e.g., Psycheceutical on 2024-07-02; HOPE South Florida on 2022-03-28; Doxee on 2021-12-09; KnowWake on 2021-09-22), creating a wide disclosed-amount spread.
Disclosed deals concentrate in a late-2024/2025 window: recent dates run from 2021-01-04 (Green Point Research) to 2025-11-07 (Lamatic). Stage labels are often non-specific: “undisclosed” appears 6 times (e.g., Thermae Retreat 2025-09-30; Remedy Well 2022-10-14), and “Series Unknown” appears 13 times (e.g., MGO Global 2024-12-23; Sunshine Biopharma 2025-04-02), making mix analysis partly driven by incomplete classifications. Sector-wise, Biotechnology recurs in 6 entries (AiM Medical Robotics; Syncromune; Sunshine Biopharma; Psycheceutical; plus Remedy Well and UpsideHoM).
Most recent rounds
47 shownRelated listings
Frequently asked
What stands out in disclosed round sizes, and is the top end meaningfully larger than the rest?
Growve’s $225M debt financing (2022-01-05) is the clear outlier: it sits far above other large disclosed rounds such as Syncromune’s $100M (2024-12-20) and EnergyX’s $75M (2024-10-04). Meanwhile, multiple entries cluster at the low disclosed end around $100K, including Psycheceutical ($100K, 2024-07-02) and KnowWake ($100K, 2021-09-22).
Do deals cluster in time near the top of the list, or are they evenly spread across years?
The displayed range spans 2021-01-04 (Green Point Research) through 2025-11-07 (Lamatic), but there is a visible density shift toward late 2024 and 2025, including multiple large disclosed rounds like EnergyX ($75M, 2024-10-04) and Syncromune ($100M, 2024-12-20). Earlier years also include major outliers such as Growve ($225M, 2022-01-05) and Ubicquia ($31M, 2022-01-13).
How often are amounts or stages not disclosed, and how does that affect interpretability of stage mix?
Stage information is frequently incomplete: “undisclosed” amounts appear 6 times (e.g., Thermae Retreat on 2025-09-30 and Remedy Well on 2022-10-14), while “Series Unknown” appears 13 times (e.g., MGO Global on 2024-12-23 and Sunshine Biopharma on 2025-04-02). This means comparisons across named stages (Seed, Series A, Series B) are made against a substantial share of rows without a specific stage label.
Which sectors repeat often enough to indicate a pattern rather than one-offs?
Biotechnology appears most consistently with 6 entries, including AiM Medical Robotics ($8M, 2025-09-29), Syncromune ($100M, 2024-12-20), Sunshine Biopharma ($3M, 2025-04-02), Psycheceutical ($100K, 2024-07-02), Remedy Well (undisclosed, 2022-10-14), and UpsideHoM ($5M, 2022-04-20). Other sectors occur fewer times in this slice, making biotech the clearest repeating cluster.
Are there notable size outliers beyond the largest disclosed round?
Yes. On the upper side, several disclosed rounds are in the $40M–$75M range (Empire Diversified Energy at $40M on 2023-06-08; Boatsetter at $38M on 2022-08-01; EnergyX at $75M on 2024-10-04), but none approach Growve’s $225M. On the lower side, the repeated $100K disclosed amount shows up across multiple sectors and years, such as Doxee ($100K, 2021-12-09) and HOPE South Florida ($100K, 2022-03-28).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.